Evaluation of frequency of device usage in patients with Fabry cardiomyopathy and sarcomeric HCM

Fabry disease (FD) is an X-linked lysosomal storage disorder with a defciency in the enzyme α-Galactosidase A. Cardiovascular complications are a cardinal feature and include progressive left ventricular hypertrophy (LVH), myocardial infammation, fbrosis, arrhythmia, congestive cardiac failure and sudden death

Copyright © 2020 Terumo India Private limited

Important information regarding

By using this website, you consent to the use of cookies in accordance with our